XOMA
John Varian,
Chief Executive Officer, Member of the Board of Directors
Paul Rubin, M.D.,,
Senior Vice President, Research and Development and Chief Medical Officer
Patrick J. Scannon, M.D., Ph.D.,
Executive Vice President, Chief Scientific Officer, and member of the Board of
Daniel P. Cafaro,
Vice President, Regulatory Affairs and Compliance
Alfred C. Dadson, Jr.,
Vice President, Manufacturing Operations
Tom Klein,
Chief Commercial Officer
Susan Kramer, Dr. P.H.,
Vice President, Product Development
Fred Kurland,
Vice President, Finance, Chief Financial Officer and Secretary
Calvin L. McGoogan,
Vice President, Quality
Rajneesh Nath, M.D.,
Vice President, Clinical
James R. Neal,
Vice President, Business Development
Charles C. Wells,
Vice President, Human Resources and Information Technology
Mark L. White,
Vice President, Research
W. Denman Van Ness,
Chairman of the Board and Lead Independent Director
Chairman, Hidden Hill Advisors
William K. Bowes Jr.,
Chairman, Nominating & Governance Committee
Founding Partner, U.S. Venture Partners
Peter Barton Hutt,
Senior Counsel, Covington & Burling; Former FDA Chief Counsel
Joseph M. Limber,
President and Chief Executive Officer, Prometheus Laboratories Inc
Kelvin M. Neu M.D.,
Managing Director, Baker Brothers
Patrick J. Scannon M.D., Ph.D.,
Founder, Executive Vice President and Chief Scientific Officer, XOMA Corporation
John Varian,
Chief Executive Officer, XOMA Corporation
Timothy P. Walbert,
President and Chief Excutive Officer, Horizon Pharma,Inc.
Jack L. Wyszomierski,
Former Executive Vice President and Chief Financial Officer, VWR International,